Considering the lack of effective anabolic therapies for treating aged and disuse-related osteoporosis, the activation of Cx43 HCs, in conjunction with moderate mechanical stimulation, holds promise as a potential therapeutic approach for patients with compromised mechanical sensitivity. Here, GJA1 is linked to osteoporosis.